Search hospitals

>

Ohio

>

Cleveland

Cleveland Clinic

Claim this profile

Cleveland, Ohio 44106

Global Leader in Cancer

Global Leader in Heart Failure

Conducts research for Lung Cancer

Conducts research for Ovarian Cancer

Conducts research for Breast Cancer

3239 reported clinical trials

285 medical researchers

Photo of Cleveland Clinic in ClevelandPhoto of Cleveland Clinic in ClevelandPhoto of Cleveland Clinic in Cleveland

Summary

Cleveland Clinic is a medical facility located in Cleveland, Ohio. This center is recognized for care of Cancer, Heart Failure, Lung Cancer, Ovarian Cancer, Breast Cancer and other specialties. Cleveland Clinic is involved with conducting 3,239 clinical trials across 2,618 conditions. There are 285 research doctors associated with this hospital, such as Rabi Hanna, Peter Rose, MD, Sabine s Coppieters, MD, and David Peereboom, MD.

Area of expertise

1

Cancer

Global Leader

Cleveland Clinic has run 182 trials for Cancer. Some of their research focus areas include:

Stage IV
Stage III
Stage I
2

Heart Failure

Global Leader

Cleveland Clinic has run 145 trials for Heart Failure. Some of their research focus areas include:

PKP2 positive
BNP positive
NT-proBNP positive

Top PIs

Clinical Trials running at Cleveland Clinic

Prostate Cancer

Cancer

Lung Cancer

Ovarian Cancer

Testicular cancer

Breast Cancer

Neuroblastoma

Obesity

Kidney Cancer

Pancreatic Cancer

Image of trial facility.

Long-Term Safety of AAA617

for Prostate Cancer

The purpose of this post-marketing study is to further characterize the long-term outcome of known or potential risks of lutetium (177Lu) vipivotide tetraxetan also known as \[177Lu\]Lu-PSMA-617 or 177Lu-PSMA-617 and hereinafter referred to as AAA617. The study also seeks to further characterize (as possible) any other AAA617 causally related serious adverse event(s) in the long-term in adults with prostate cancer who received at least one dose of AAA617 from interventional, Phase I-IV Novartis sponsored clinical trials.

Recruiting

3 awards

Phase 4

Image of trial facility.

Shorter vs Usual Radiation Therapy

for Prostate Cancer

This phase III trial compares stereotactic body radiation therapy (SBRT), (five treatments over two weeks using a higher dose per treatment) to usual radiation therapy (20 to 45 treatments over 4 to 9 weeks) for the treatment of high-risk prostate cancer. SBRT uses special equipment to position a patient and deliver radiation to tumors with high precision. This method may kill tumor cells with fewer doses over a shorter period of time. This trial is evaluating if shorter duration radiation prevents cancer from coming back as well as the usual radiation treatment.

Recruiting

2 awards

Phase 3

10 criteria

Image of trial facility.

Xaluritamig vs Other Treatments

for Prostate Cancer

The main objective of the study is to compare overall survival in participants receiving xaluritamig versus investigator's choice (cabazitaxel or second androgen receptor-directed therapy \[ARDT\]).

Recruiting

2 awards

Phase 3

4 criteria

Similar Hospitals nearby

Frequently asked questions

What kind of research happens at Cleveland Clinic?

Where is Cleveland Clinic located?

Who should I call to ask about financial aid or insurance network?

What insurance does Cleveland Clinic accept?

What awards or recognition has Cleveland Clinic received?